News & Events
Malaghan researchers identify new role for key molecule in e...
Researchers at the Malaghan Institute of Medical Research have identified the role a ...
Scope 64 - Ankle-tapping cancer: reducing therapy resistance...
Cancer is particularly good at shrugging off whatever is thrown at it, ploughing ...
Scope 64 - Translational immunology leading the way with hig...
How can New Zealand companies leverage the relationship between food and our immu...
Scope 64 - What do parasites have to say about allergic dise...
You wouldn’t think a tiny helminth would have much to say about allergies, yet thi...
Scope 64 - New spectral cytometer is out of this world
The Malaghan Institute is excited to welcome a new spectral cytometer to the Hugh ...
Scope 64 - The private life of cells: seeing the big picture
Getting up close and personal with cells is a complicated task. Are the cells doin...
Scope 64 - Research in focus: Cancer immunotherapy
The Cancer Immunotherapy programme has successfully completed the latest round of ...
Scope 64 - Research in focus: Multiple Sclerosis
The Multiple Sclerosis team has been working with a New Zealand biomedical company...
Scope 64 - Malaghan Institute Research Updates: connecting s...
Throughout the year, the Malaghan Institute hosts a number of research updates ac...
Scope 64 - Our people: Dr Laura Ferrer-Font
As the potential of immunotherapy grows, so must our team of specialised staff an...